|  | 
| Prevalence of HRR gene mutations in patients with metastatic castration-resistant prostate cancer: Germline results from the Latin-American observational study PROSPECT. | 
|  | 
|  | 
| Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Grupo Biotoscana; Ipsen; Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Tecnofarma | 
| Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Grupo Biotoscana; Ipsen; Janssen; Lilly; MSD; Pfizer; Tecnofarma | 
| Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Tecnofarma | 
| Research Funding - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Grupo Biotoscana; Ipsen; Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Tecnofarma | 
| Expert Testimony - Astellas Pharma; Bayer; Janssen; MSD | 
| Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; MSD | 
|  | 
|  | 
| Honoraria - AstraZeneca; Janssen; Roche | 
| Speakers' Bureau - AstraZeneca; Janssen; Roche | 
| Research Funding - AstraZeneca; AstraZeneca (Inst) | 
|  | 
|  | 
| Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Roche | 
| Consulting or Advisory Role - Astellas Pharma; Ipsen; Roche | 
| Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Roche | 
| Research Funding - AstraZeneca (Inst) | 
| Expert Testimony - AstraZeneca; Bristol-Myers Squibb; MSD; Roche | 
| Travel, Accommodations, Expenses - Bristol-Myers Squibb; Raffo | 
|  | 
|  | 
| Consulting or Advisory Role - AstraZeneca | 
| Speakers' Bureau - AstraZeneca | 
| Research Funding - AstraZeneca | 
|  | 
|  | 
| Honoraria - Astellas Pharma; AstraZeneca; AstraZeneca; Bayer | 
| Speakers' Bureau - AstraZeneca; Bayer; Bristol-Myers Squibb; Pfizer | 
| Research Funding - Bayer; Bristol-Myers Squibb; Pfizer (Inst) | 
|  | 
| Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Merck; Merck Serono; Pfizer | 
|  | 
|  | 
|  | 
| Consulting or Advisory Role - AstraZeneca | 
| Speakers' Bureau - AstraZeneca | 
| Travel, Accommodations, Expenses - Janssen | 
|  | 
|  | 
|  | 
|  | 
|  | 
|  | 
| Stock and Other Ownership Interests  - AstraZeneca | 
|  | 
|  | 
|  | 
| No Relationships to Disclose | 
|  | 
|  | 
| Consulting or Advisory Role - AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Pfizer | 
| Speakers' Bureau - Bayer (Inst); Caris Life Sciences (Inst); Pfizer/Astellas (Inst) | 
| Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Merck (Inst); Pfizer (Inst) |